Brain IL-6 - Where amylin and GLP-1 antiobesity signaling congregate

Diabetes

Volumn 64, Issue 5, 2015, Pages 1498-1499

  Jansson, John Olov ^a   Palsdottir, Vilborg ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; ANTIOBESITY AGENT; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; INTERLEUKIN 6; LEPTIN; PRAMLINTIDE;

BODY WEIGHT; BRAIN; CACHEXIA; DIABETES MELLITUS; FOOD INTAKE; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; NAUSEA; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH EMPTYING; ANIMAL; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; INTERLEUKIN-6; ISLET AMYLOID POLYPEPTIDE; LEPTIN; MALE; SIGNAL TRANSDUCTION; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 84934343351     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1910     Document Type: Note

References (20)

1. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-671
2. Grill HJ, Hayes MR. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab 2012;16:296-309
3. Le Foll C, Johnson MD, Dunn-Meynell AA, Boyle CN, Lutz TA, Levin BE. Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling. Diabetes 2015;64:1621-1631
4. Hayes MR, Mietlicki-Baase EG, Kanoski SE, De Jonghe BC. Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose. Annu Rev Nutr 2014;34: 237-260
5. Lutz TA. The interaction of amylin with other hormones in the control of eating. Diabetes Obes Metab 2013;15:99-111
6. Roth JD, Roland BL, Cole RL, et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci U S A 2008;105:7257-7262
7. Younk LM, Mikeladze M, Davis SN. Pramlintide and the treatment of diabetes: a review of the data since its introduction. Expert Opin Pharmacother 2011;12:1439-1451
8. Shirazi R, Palsdottir V, Collander J, et al. Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6. Proc Natl Acad Sci U S A 2013;110:16199-16204
9. Holst JJ, Deacon CF. Is there a place for incretin therapies in obesity and prediabetes? Trends Endocrinol Metab 2013;24:145-152
10. Ezcurra M, Reimann F, Gribble FM, Emery E. Molecular mechanisms of incretin hormone secretion. Curr Opin Pharmacol 2013;13:922-927
11. Murakami M, Hirano T. The pathological and physiological roles of IL-6 amplifier activation. Int J Biol Sci 2012;8:1267-1280
12. Lonnroth C, Gelin J, Lundholm K. Expression of interleukin-6 in tumorbearing mice with cytokine dependent cachexia. Int J Oncol 1994;5:329-336
13. Matthews VB, Allen TL, Risis S, et al. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010;53:2431-2441
14. Wallenius V, Wallenius K, Ahrén B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002;8:75-79
15. Hidalgo J, Florit S, Giralt M, Ferrer B, Keller C, Pilegaard H. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav Immun 2010;24:119-126
16. Sadagurski M, Norquay L, Farhang J, D'Aquino K, Copps K, White MF. Human IL6 enhances leptin action in mice. Diabetologia 2010;53:525-535
17. Wallenius K, Wallenius V, Sunter D, Dickson SL, Jansson JO. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 2002;293:560-565
18. Flores MB, Fernandes MF, Ropelle ER, et al. Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 2006;55:2554-2561
19. Richard JE, Farkas I, Anesten F, et al. GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence. Endocrinology 2014;155:4356-4367
20. Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011;17:1481-1489